1. Home
  2. STXS vs GCMG Comparison

STXS vs GCMG Comparison

Compare STXS & GCMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STXS
  • GCMG
  • Stock Information
  • Founded
  • STXS 1990
  • GCMG 1971
  • Country
  • STXS United States
  • GCMG United States
  • Employees
  • STXS N/A
  • GCMG N/A
  • Industry
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • GCMG Finance/Investors Services
  • Sector
  • STXS Health Care
  • GCMG Finance
  • Exchange
  • STXS Nasdaq
  • GCMG Nasdaq
  • Market Cap
  • STXS 151.3M
  • GCMG N/A
  • IPO Year
  • STXS 2004
  • GCMG N/A
  • Fundamental
  • Price
  • STXS $2.18
  • GCMG $12.34
  • Analyst Decision
  • STXS
  • GCMG Hold
  • Analyst Count
  • STXS 0
  • GCMG 5
  • Target Price
  • STXS N/A
  • GCMG $14.20
  • AVG Volume (30 Days)
  • STXS 285.8K
  • GCMG 398.7K
  • Earning Date
  • STXS 05-12-2025
  • GCMG 05-07-2025
  • Dividend Yield
  • STXS N/A
  • GCMG 3.57%
  • EPS Growth
  • STXS N/A
  • GCMG N/A
  • EPS
  • STXS N/A
  • GCMG 0.11
  • Revenue
  • STXS $26,918,000.00
  • GCMG $528,715,000.00
  • Revenue This Year
  • STXS $25.90
  • GCMG $9.11
  • Revenue Next Year
  • STXS $60.57
  • GCMG $10.63
  • P/E Ratio
  • STXS N/A
  • GCMG $113.49
  • Revenue Growth
  • STXS 0.55
  • GCMG 16.99
  • 52 Week Low
  • STXS $1.54
  • GCMG $9.25
  • 52 Week High
  • STXS $2.72
  • GCMG $14.48
  • Technical
  • Relative Strength Index (RSI)
  • STXS 66.61
  • GCMG 41.25
  • Support Level
  • STXS $1.93
  • GCMG $12.02
  • Resistance Level
  • STXS $2.07
  • GCMG $12.80
  • Average True Range (ATR)
  • STXS 0.09
  • GCMG 0.29
  • MACD
  • STXS 0.03
  • GCMG 0.04
  • Stochastic Oscillator
  • STXS 94.05
  • GCMG 47.16

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: